NEI Research News

In a major step forward in the battle against macular degeneration, researchers at the University of Virginia School of Medicine have discovered a critical trigger for the damaging inflammation that ultimately robs millions of their sight.

The breast cancer drug tamoxifen appears to protect light-sensitive cells in the eye from degeneration, according to a new study in mice.

NEI-funded scientists from The Scripps Research Institute have discovered how a protein called α2δ4 establishes proper vision.

A tiny, transparent device that can fit into a contact lens has a bright future, potentially helping a range of scientific endeavors from biomedicine to geology.

The University of Southern California (USC) Roski Eye Institute researchers and clinicians published results of the largest population-based study of adult Latinos and age-related macular degeneration (AMD).

In a study of nearly 650 people with the eye disease age-related macular degeneration (AMD), half still had vision 20/40 or better after five years of treatment with anti-VEGF drugs that are injected into the eye.

Researchers and clinicians at the University of Southern California Roski Eye Institute have published results of the NEI-funded “Chinese American Eye Study” in JAMA Ophthalmology.

Researchers at LSU Health New Orleans have shown that a protein critical to the body’s ability to remove waste products from the brain and retina is diminished in age-related macular degeneration.

Our eyes are especially demanding when it comes to energy: Along with our brain, they require a substantial amount of power to keep them functioning and healthy.

An international study of about 43,000 people has significantly expanded the number of genetic factors known to play a role in age-related macular degeneration (AMD), a leading cause of vision loss among people age 50 and older.